Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI
Sponsor: Mohammad Hussien Tantawy Soliman
Summary
This study aims to investigate the effect of early administration of DAPA during ischemia and before pPCI on infarct size, reperfusion injury-related myocardial damage, cardioprotection from HF, and renoprotection from AKI in patients with AMI.
Official title: Clinical Investigation of Cardioprotective Effect of Early Administration of Sodium-glucose Cotransport-2 Inhibitors in Patients With Acute Myocardial Infarction
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2023-10
Completion Date
2026-08
Last Updated
2023-08-24
Healthy Volunteers
No
Conditions
Interventions
Dapagliflozin 10mg Tab
patients will be treated with DAPA 10 mg once daily for three months
Placebo
patients will be treated with a placebo tab once daily for three months
Locations (1)
Mohammad Soliman
Shibīn al Kawm, Menofia, Egypt